Elliott Management

News

Activist investor Elliott turns its attention to BioMarin

Hedge Fund Elliott Management has bought a big stake in BioMarin Pharma, causing a spike in the company’s share price, and started discussions with the company about its s

News

Second hedge fund applies pressure on GSK after taking stake

Activist hedge fund Bluebell Capital Partners has joined Elliott Investment in taking a stake in GlaxoSmithKline and pushing for change at the pharma company.

News

GSK backs CEO Walmsley, rejecting Elliott's call to change b...

GlaxoSmithKline's board had responded to the broadside attack delivered by activist investor Elliott Management yesterday, saying it stands firmly behind the leadership of chief executive E

News

Elliott fires broadside at GSK in wake of investor update

GlaxoSmithKline chief executive Emma Walmsley was no doubt hoping that an upbeat assessment of the firm's prospects at an investor meeting last week would deflect criticism of her leadershi

News

Under-pressure GSK sells stake in respiratory diseases partn...

GlaxoSmithKline has sold its entire stake in its respiratory partner Innoviva, raising $392 million and simplifying its business ahead of a split into two.

News